FSP1 (fibroblastspecific protein 1) was originally considered a marker of fibroblasts, but recent studies have confirmed that it is primarily expressed by a proinflammatory macrophage subset in liver injury and participates in the regulation of inflammation and fibrosis. This study systematically explores the interplay among these three elements.

Polymer-based flexible wireless sensors have demonstrated significant potential in health monitoring. However, existing studies have predominantly focused on material design, energy harvesting, and wireless communication, while research addressing signal attenuation, noise accumulation, and data distortion within wireless links remains relatively limited. Physiological signals are highly susceptible to multi-source interference during acquisition and transmission; without effective data processing and intelligent analysis strategies, monitoring outcomes may fail to meet the accuracy and stability requirements of clinical applications. To address this research gap, this review constructs a comprehensive framework encompassing signal sensing, link transmission, and intelligent processing, building on advances in flexible materials and wireless energy supply modes. Special attention is given to the critical roles of channel compensation, noise suppression, feature extraction, lightweight artificial intelligence models, and edge computing in enhancing data quality and reducing energy consumption. Furthermore, the review systematically analyzes the impact of wireless link stability and energy management on monitoring performance. By reinforcing the synergistic mechanisms between data processing and communication, this work aims to provide design principles and development directions for the next generation of high-reliability, low-power, and intelligent wireless flexible health monitoring systems.

Indefinite lenalidomide maintenance has long been standard care for standard-risk newly diagnosed multiple myeloma patients not undergoing stem cell transplants, despite little evidence to guide the optimal duration of treatment. The ECOG-ACRIN ENDURANCE trial, published in the New England Journal of Medicine, found more toxicity with no survival benefit from continuing maintenance beyond 2 years, providing evidence to change clinical practice.  

A condition affecting approximately 170 million adolescents and women worldwide has a new name – one that better reflects its complexity and far-reaching health impacts.

Polycystic ovary syndrome, PCOS, has long been understood as a reproductive disorder. But a recent paper published in The Lancet proposes renaming it polyendocrine metabolic ovarian syndrome, PMOS, to more accurately capture what researchers now know about the condition: it is not just about the ovaries, but about the entire body.